TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
ADAG

Adagene Inc

Healthcare · Biotechnology

2.90$ -8.4% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement ADAG
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
– – – – – – 897.5% 7.6%
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% -797.5% 100.0%
1,064.1% 3,377.4% 3,377.4% 669.3% 875.3% 202.3% 27,887.9% 287.2%
183.0% 716.2% 716.2% 141.9% 127.8% 47.9% 7,047.5% 92.2%
1,247.1% 4,093.7% 4,093.7% 811.2% 1,003.1% 231.0% 34,935.4% 379.5%
-1,147.1% -3,993.7% -3,993.7% -711.2% -903.1% -131.0% -34,835.4% -279.5%
6.0% 28.8% 42.1% 3.6% 7.5% 6.1% 825.4% 6.0%
-1,010.2% -3,423.4% -3,423.4% -702.5% -855.6% -95.3% -32,403.5% -233.4%
-36.2% 179.5% 0.7% 16.7% 4.9% 9.3% -17.0% -3.9%
-974.0% -3,602.9% -3,424.1% -719.2% -860.6% -104.6% -32,386.4% -229.6%
-944.0% -3,224.5% -8,611.8% -687.8% -832.8% -82.5% -30,680.5% -219.7%

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?